Clinical Trial Update: A Single-center Clinical Study to Evaluate the Safety and Efficacy of Autologous Bone Marrow-derived DCs(CellgramDC-WT1) and Immune Checkpoint Inhibitors in Patients With Metastatic Pancreatic Cancer Who Have Failed First-line or More Standard Chemotherapy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating autologous bone marrow–derived dendritic cells (CellgramDC-WT1) in combination with immune checkpoint inhibitors for metasta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• CellgramDC-WT1 (dendritic cell vaccine)

Snippet

Sponsor: Soonchunhyang University Hospital | Conditions: Pancreas Cancer | Phase 1, Phase 2 | Status: UNKNOWN